It has been shown that the expression level of 7SK was down-regulated in breast cancer, colon cancer, and Chronic Myelogenous Leukemia (CML) (Abasi et al., 2016). This evidence concerns the gene 7SK and chronic myelogenous leukemia, BCR-ABL1 positive.